We are proud to announce the beginning of a clinical trial for Vitastiq personal device. The aim of the clinical trial is to determine the accuracy of Vitastiq device which helps to indicate the user's vitamin and mineral trend and offers information about essential nutrients and their natural sources. Recruitment is planned from May 20th 2017 till August 15th 2017.
If you would like to participate in this study and live in Slovenia, we would kindly invite you to visit our web page www.vizera.eu/vitastiq.
Vizera will attend the HIE 2016 – Health Ingredients Europe, which will be held between 29th November and 1st December 2016, in Frankfurt, Germany.
We will be presenting our services at the exhibition booth No. K73. You are very welcome to stop by, and we will be happy to speak with you and exchange ideas for collaboration.
On December 10, Vizera commemorates Human Rights Day - a day to raise awareness about all people who still do not have access to a highest attainable health protection.
In article 25 of the United Nations' Universal Declaration of Human Rights it is stated that everyone has the right to a standard of living adequate for the health and well-being of himself and of his family; including food, clothing, housing and medical care and necessary social services. We all know that appropriate sanitation, adequate food, clean and safe environment, advanced medical practices, and quality medicines are not self-evident everywhere.
Health care, as all other basic rights, must be provided as a public good for all - every child, youth, woman and man has the right to the highest attainable standard of physical and mental health, without discrimination of any kind. Everyone deserves the health care they need, and living conditions that enable us to be healthy, because this is vital to achieve full participation in society and supports progress.
Health disparities are unfair differences around the world, because they are preventable. Effective interventions can be done to minimize inequalities. Every individual could start with maintaining clean environment, reducing discrimination; more influential individuals and organizations should strive to more revolutionary changes and mobilize action to access fair medical care.
Vizera strives to contribute to this effort with high ethical and quality standards; trying locally to bring studies to as much patients as possible by encouraging Sponsors to extend their trials to the region, and by motivating Investigators and clinical staff.
Vizera will attend the OCTEEC 2015 – The International Conference on Outsourcing Clinical Trials in Emerging European Countries, which will be held between 1st and 2nd October 2015, in Bucharest, Romania.
We will be presenting our services at the exhibition booth No. 10. You are very welcome to stop by, and we will be happy to speak with you and exchange ideas for collaboration.
Follow us on Twitter @VizeraCRO to get further updates. #OCTCEE2015
On 20th May, Vizera is joining clinical research community around the world in celebration of the International Clinical Trials Day.
It is well known how important the clinical research is to the advancement in medicine and consequently to general health care. Providing the treatment of the highest quality to patients in all parts of the world is a significant job, and Vizera is proud to be a small link in this important network of researchers, organizations, and clinical staff.
It is also encouraging how the nutraceutical industry is increasingly understanding the importance of testing the safety and efficacy of their products, and thus protecting the end user and assuring that only high-quality products are marketed.
On this occasion, we would like to thank all our business partners, collaborators, and especially the investigators and their staff for their dedication and generous sharing of their expertise and time.
Vizera has successfully completed the clinical trial with probiotic product on lactose intolerant individuals.
In a placebo controlled, double-blind, randomized clinical trial the efficacy of a probiotic product was proven in lactose intolerant individuals. All typical symptoms of lactose intolerance (diarrhea, nausea, abdominal pain, stomach rumbling, and bloating) have declined after the treatment with the tested product.
The beneficial outcome of the clinical trial is the result of the effective product combined with our well-planned protocol and conduction of the clinical trial.
We are proud to provide our customer with applicable results for their valuable product.
The European Commission has just announced the results of Horizon 2020 WIDESPREAD-2014-1 TEAMING call.
The project ARTEMIDA (Advanced Regional Translation of Excellence into Medical Innovation for Delayed Aging) was excellently evaluated and was chosen for EU funding. The aim of the project is to develop a new Centre of Excellence for Translational Medicine and to improve diagnostics and treatment strategies, mainly in the fields of neurodegenerative disease, diabetes, rheumatoid arthritis and cancer.
The consortium combines Slovenian biomed institutions lead by the University of Ljubljana with support of industrial research and innovation partner institutions and the leading scientific institutions Karolinska Institutet, Sweden and The European Molecular Biology Laboratory – The European Bioinformatics Institute, Germany.
We would like to welcome you at our stand at the new International Pharmabiotics Conference in Paris on 29 and 30 October 2014. The Conference addresses the new findings on treating common diseases with probiotics. There will be many interesting lectures given by prominent speakers. Let’s meet there.
We are excited to announce that we have given our website a makeover, redesigning it to display optimally across smartphones, tablet devices and desktop computers. You will now be able to easily and quickly find the content you are looking for, regardless of the type of the device you are using.
EFSA has invited everybody to open discussion on the scientific requirements for health claims related to gut and immune function guidance. Submit your comments by 10 September 2014.
Vizera has a wealth of experience in clinical trials of pharmaceuticals and nutraceuticals and provides support with EFSA claim submission. We are highly skilled in several therapeutic areas, some of which include gastroenterology, cognitive functions, paediatric health, and the immune and cardiovascular systems.
Vizera’s project managers and experts work in a wide range of product development areas and are completely focused on achieving their goals regarding the development of pharmaceutical and nutraceutical products – from the initial concept right through to registration.
Before a product can be used, sold, supplied, advertised or stored, it must be approved for use. Vizera helps you make the right decisions on how to register your product in the EU in order to avoid incurring additional time and financial costs.